Literature DB >> 10998553

Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease.

F Panza1, V Solfrizzi, F Torres, F Mastroianni, A M Colacicco, A M Basile, C Capurso, A D'Introno, A Del Parigi, A Capurso.   

Abstract

Apolipoprotein E (apoE) polymorphism was evaluated in 81 sporadic late onset Alzheimer's disease (LOAD) patients, 28 sporadic early-onset Alzheimer's disease (EOAD) and 92 sex- and age-matched healthy controls from Apulia, Southern Italy. ApoE genotypes were determined by the polymerase chain reaction-restriction fragment length polymorphism method. The frequency of apoE epsilon 4 allele was significantly higher in EOAD patients than in the control group, but not in LOAD patients. Furthermore, EOAD patients carrying epsilon 4 allele had lower age at onset of AD symptoms (about 4. 5 years). In the whole sample, epsilon 4 was associated to AD by an odds ratio of 2.14, while it increased up to 6.55 in < 65 years old subjects. Finally, in both < 65 and > or = 65 subgroups of subjects, epsilon 2 played a protective role against the development of AD. It is concluded that the geographic decreasing trend of epsilon 4 allele and the age at onset may influence the association of apoE polymorphism with sporadic AD in a Southern Italian sample.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998553     DOI: 10.1016/s0304-3940(00)01447-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.

Authors:  Anna Juhász; Agnes Rimanóczy; Krisztina Boda; Gábor Vincze; Gyozo Szlávik; Marianna Zana; Annamária Bjelik; Magdolna Pákáski; Nikoletta Bódi; András Palotás; Zoltán Janka; János Kálmán
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.

Authors:  Shraddha Sapkota; Lars Bäckman; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2017-01-03       Impact factor: 4.673

3.  Differences between early and late onset Alzheimer's disease.

Authors:  Peter K Panegyres; Huei-Yang Chen
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

4.  Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease.

Authors:  V Solfrizzi; F Panza; A D'Introno; A M Colacicco; C Capurso; A M Basile; A Capurso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

5.  NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load.

Authors:  Theresa Pohlkamp; Xunde Xian; Connie H Wong; Murat S Durakoglugil; Gordon Chandler Werthmann; Takaomi C Saido; Bret M Evers; Charles L White; Jade Connor; Robert E Hammer; Joachim Herz
Journal:  Elife       Date:  2021-10-07       Impact factor: 8.713

6.  Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.

Authors:  Shraddha Sapkota; David Vergote; David Westaway; Jack Jhamandas; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2014-06-20       Impact factor: 4.673

7.  Interaction of ApoE3 and ApoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory.

Authors:  Fabrizio Biundo; Keita Ishiwari; Dolores Del Prete; Luciano D'Adamio
Journal:  Neurobiol Learn Mem       Date:  2015-10-31       Impact factor: 2.877

8.  Volumetric distribution of perivascular space in relation to mild cognitive impairment.

Authors:  Farshid Sepehrband; Giuseppe Barisano; Nasim Sheikh-Bahaei; Jeiran Choupan; Ryan P Cabeen; Kirsten M Lynch; Malcolm S Crawford; Haoyu Lan; Wendy J Mack; Helena C Chui; John M Ringman; Arthur W Toga
Journal:  Neurobiol Aging       Date:  2020-12-16       Impact factor: 4.673

9.  Protective effect of the APOE-e3 allele in Alzheimer's disease.

Authors:  B V P de-Almada; L D de-Almeida; D Camporez; M V D de-Moraes; R L Morelato; A M S Perrone; L Belcavello; I D Louro; F de-Paula
Journal:  Braz J Med Biol Res       Date:  2011-11-08       Impact factor: 2.590

10.  Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimer's Disease in the Lithuanian Population.

Authors:  Greta Pšemeneckienė; Kęstutis Petrikonis; And Daiva Rastenytė
Journal:  Medicina (Kaunas)       Date:  2019-10-15       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.